Your browser doesn't support javascript.
loading
Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
Mannangatti, Padmanabhan; Sundaramurthy, Santhanalakshmi; Ramamoorthy, Sammanda; Jayanthi, Lankupalle D.
Affiliation
  • Mannangatti P; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA.
  • Sundaramurthy S; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA.
  • Ramamoorthy S; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA.
  • Jayanthi LD; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, 23298, USA. lankupalle.jayanthi@vcuhealth.org.
Psychopharmacology (Berl) ; 234(4): 695-705, 2017 Feb.
Article in En | MEDLINE | ID: mdl-28013351
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reward / Morpholines / Conditioning, Psychological / Neurokinin-1 Receptor Antagonists / Central Nervous System Stimulants / Analgesics, Opioid Type of study: Prognostic_studies Limits: Animals Language: En Journal: Psychopharmacology (Berl) Year: 2017 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reward / Morpholines / Conditioning, Psychological / Neurokinin-1 Receptor Antagonists / Central Nervous System Stimulants / Analgesics, Opioid Type of study: Prognostic_studies Limits: Animals Language: En Journal: Psychopharmacology (Berl) Year: 2017 Type: Article Affiliation country: United States